Profilo
Robert Coffin was the founder of BioVex, Inc. (1999, Chief Technology Officer), BioVex Group, Inc. (1999, Director & Chief Technology Officer), Replimune Group, Inc. (2015, Director & Chief Scientist), and Replimune Ltd. (2015, Chief Executive Officer).
Former job at BioVex Ltd. (1999-2011, Director & Chief Technology Officer) and Amgen, Inc. (2011-2013, Vice President-Global Development).
Education includes a doctorate from Imperial College London (1991).
Precedenti posizioni note di Robert Coffin
| Società | Posizione | Fine |
|---|---|---|
| REPLIMUNE GROUP, INC. | Amministratore Delegato | 09/01/2020 |
Replimune Ltd.
Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Research and develops cancer therapeutics | Amministratore Delegato | 10/07/2017 |
| AMGEN INC. | Corporate Officer/Principal | 01/01/2013 |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Direttore Tecnico/Scientifico/R&S | 04/03/2011 |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Fondatore | 01/01/2011 |
Formazione di Robert Coffin
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 7 |
|---|---|
Amgen, Inc.
Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
BioVex, Inc.
BioVex, Inc. Pharmaceuticals: MajorHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
BioVex Group, Inc.
BioVex Group, Inc. BiotechnologyHealth Technology Develops vaccines for the treatment of cancer and the prevention of chronic infectious diseases | Health Technology |
Imperial College London
Imperial College London Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
BioVex Ltd.
BioVex Ltd. Miscellaneous Commercial ServicesCommercial Services Develops and commercializes biological treatments for cancer and infectious diseases | Commercial Services |
Replimune Group, Inc.
Replimune Group, Inc. BiotechnologyHealth Technology Develops oncolytic immunotherapies | Health Technology |
Replimune Ltd.
Replimune Ltd. Miscellaneous Commercial ServicesCommercial Services Research and develops cancer therapeutics | Commercial Services |
















